Research Roundup

OFFICIAL PUBLICATION OF

by its subsidiary APPco

Debbie Rigby 26/01/2021

Debbie Rigby rounds up the latest in research news Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease Long‐term use of proton pump inhibitors (PPIs) has been associated with adverse kidney events in the general population. In patients with chronic kidney disease, long-term PPI prescription is common, increasing the risk of progression

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

Teal questions pharmacist UTI programs

because much of the time, I think they’re giving antibiotics for things that are not UTIsPolitician says "I think" and…

Michael Hewson

Medics to ‘fight’ Doctor of Pharmacy title

Yet right now there are far too many reports from overseas of patients being unsure whether their care is from…

Michael Hewson

In scarce supply

I love a good joke.

Evan Nickols

Concurrent funding for aged care pharmacists and RMMRs needed

I understood that was to happen as a gradual changeover and not an abrupt cessation. Currently we do not have…

Jenny Gowan

Research Roundup

Previous GP forged scripts, breached conditions

Next Pharmacists honoured on Australia Day

Ceramides: what are they and why are they important?

In the beginning

The signs of ageing

Hyperpigmentation

MENU

Previous GP forged scripts, breached conditions

Next Pharmacists honoured on Australia Day

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.